A Falanga, M Marchetti - Thrombosis Research, 2012 - thrombosisresearch.com
Venous thromboembolic (VTE) complications are common in patients with cancer and represent the second cause of death in this disease. The risk of VTE varies according to the …
A Falanga, M Marchetti - Thrombosis Research, 2012 - infona.pl
Venous thromboembolic (VTE) complications are common in patients with cancer and represent the second cause of death in this disease. The risk of VTE varies according to the …
A Falanga, M Marchetti - Thrombosis research, 2012 - pubmed.ncbi.nlm.nih.gov
Venous thromboembolic (VTE) complications are common in patients with cancer and represent the second cause of death in this disease. The risk of VTE varies according to the …
A Falanga, M Marchetti - Thrombosis Research, 2011 - europepmc.org
Venous thromboembolic (VTE) complications are common in patients with cancer and represent the second cause of death in this disease. The risk of VTE varies according to the …
A Falanga, M Marchetti - Thrombosis Research, 2012 - researchgate.net
Venous thromboembolism (VTE) is a common complication in cancer patients which significantly impacts on mortality and quality of life of the affected subjects [1]. Indeed …
A Falanga, M Marchetti - Thrombosis Research, 2012 - academia.edu
Venous thromboembolism (VTE) is a common complication in cancer patients which significantly impacts on mortality and quality of life of the affected subjects [1]. Indeed …
A Falanga, M Marchetti - Thrombosis Research, 2012 - academia.edu
Venous thromboembolism (VTE) is a common complication in cancer patients which significantly impacts on mortality and quality of life of the affected subjects [1]. Indeed …